Mónica Rodríguez Carballeira

Summary

Country: Spain

Publications

  1. ncbi The bronchodilator test with increasing doses of terbutaline in chronic obstructive pulmonary disease patients
    M Rodriguez-Carballeira
    Department of Internal Medicine, Hospital Mutua de Terrassa, Barcelona, Spain
    Pulm Pharmacol Ther 14:61-5. 2001
  2. ncbi The bronchodilator test in chronic obstructive pulmonary disease: interpretation methods
    M Rodriguez-Carballeira
    Department of Internal Medicine, Hospital Mutua de Terrassa, Plaza Dr Robert, 5, 08221 Terrassa, Barcelona, Spain
    Respir Med 101:34-42. 2007
  3. ncbi [Bilateral suprarenal hematoma in a 46-year-old male]
    Mónica Rodríguez Carballeira
    Servicio de Medicina Interna, Hospital Mutua de Terrassa, Terrassa, Barcelona España
    Med Clin (Barc) 130:71-7. 2008
  4. ncbi Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease
    Pedro Almagro
    Department of Internal Medicine, Hospital Mutua de Terrassa, University of Barcelona, Barcelona, Spain
    Respiration 73:311-7. 2006
  5. ncbi Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis
    Carolina Garcia Vidal
    Service of Internal Medicine, Hospital Mutua de Terrassa, University of Barcelona, Barcelona, Spain
    Clin Infect Dis 40:756-9. 2005

Collaborators

  • M Rue
  • Pedro Almagro
  • M Rodriguez-Carballeira
  • Carolina Garcia Vidal
  • J L Heredia
  • S Quintana
  • Miquel Salavert
  • Javier Martinez Lacasa
  • Serena Rodríguez Fernández
  • Rafael Vidal
  • Javier Garau
  • L Gomez

Detail Information

Publications5

  1. ncbi The bronchodilator test with increasing doses of terbutaline in chronic obstructive pulmonary disease patients
    M Rodriguez-Carballeira
    Department of Internal Medicine, Hospital Mutua de Terrassa, Barcelona, Spain
    Pulm Pharmacol Ther 14:61-5. 2001
    ..004). The higher dose of terbutaline was more useful in identifying patients with significant bronchoreversibility and, moreover, was well tolerated. We suggest that this dose (1500 microg) should be routinely used in performing the BDT...
  2. ncbi The bronchodilator test in chronic obstructive pulmonary disease: interpretation methods
    M Rodriguez-Carballeira
    Department of Internal Medicine, Hospital Mutua de Terrassa, Plaza Dr Robert, 5, 08221 Terrassa, Barcelona, Spain
    Respir Med 101:34-42. 2007
    ..3, and the "percentage with respect to the predicted" with a cut point of 6%...
  3. ncbi [Bilateral suprarenal hematoma in a 46-year-old male]
    Mónica Rodríguez Carballeira
    Servicio de Medicina Interna, Hospital Mutua de Terrassa, Terrassa, Barcelona España
    Med Clin (Barc) 130:71-7. 2008
  4. ncbi Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease
    Pedro Almagro
    Department of Internal Medicine, Hospital Mutua de Terrassa, University of Barcelona, Barcelona, Spain
    Respiration 73:311-7. 2006
    ..Hospital readmissions for acute exacerbation of chronic obstructive pulmonary disease (COPD) are one of the leading causes of health care expenditures worldwide...
  5. ncbi Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis
    Carolina Garcia Vidal
    Service of Internal Medicine, Hospital Mutua de Terrassa, University of Barcelona, Barcelona, Spain
    Clin Infect Dis 40:756-9. 2005
    ..Physicians should be aware of the increased risk of a paradoxical response in this population and should consider the use of corticosteroids when a paradoxical reaction is suspected...